More PRNewswire
View Older Stories View Newer Stories-
Orange Finances Money Mali and TerraPay Forge Strategic Partnership for Seamless Cross-border Payments
-
Scholastic Appoints Haji Glover as Chief Financial Officer
-
NIH Deploys Picodya's B-Matrix In Vitro Diagnostics Platform to Detect Global Viral Threats
-
Spirit AeroSystems Statement - Alaska Airlines Flight 1282
-
3M announces U.S. pension plan actions
-
STORAGE STRUCTURES IS NOW ELEVATE STRUCTURES
-
TETRA TECHNOLOGIES, INC., ANNOUNCES COMPLETION OF TECHNICAL RESOURCES STUDY FOR THE ARKANSAS LITHIUM AND BROMINE BRINE UNIT
-
RCA Accessories To Expand its Presence in the Multi-Billion-Dollar Over-the-Counter Hearing Aid Market with the Launch of Three New Premium RCA Models
-
BILL CRAGER ANNOUNCES DECISION TO TRANSITION FROM CEO OF ENVESTNET AFTER MORE THAN TWO DECADES AT THE COMPANY
-
COSMIC WIRE TO UNVEIL CUTTING-EDGE IMMERSIVE SPATIAL WEB TECHNOLOGIES AT 2024 CES TRADE SHOW
-
Northstar Clean Technologies and IKO Industries Announce Five-year Manufacturing Waste Asphalt Shingle Supply Agreement for Northstar's Empower Calgary Facility
-
Formovie Technology Announces Next-Generation Projectors at CES 2024: A Must-See for Tech Enthusiasts
-
HanaByte joins Google Cloud Partner Advantage
-
Phil Gyori Named Chief Executive Officer of United Sports Brands
-
TACO BELL® ENTERS A NEW VALUE ERA WITH THE LAUNCH OF THE NEW CRAVINGS VALUE MENU
-
National Safety Council Launches Fleet Essentials Training Program
-
Roo Reveals Remarkable Earnings Potential Generational Shifts toward Flexible Work among Veterinarians Nationwide
-
Alimentiv Announces Pierre Gaudreault as New Chief Executive Officer
-
Cipla announces joint venture in the United States with Kemwell Biopharma and Manipal Education & Medical Group for global development and commercialisation of innovative Cell therapy products
-
BrainCheck Appoints Aaron Greenstein, MD to Clinical Advisory Board
-
Regen BioPharma, Inc. to Present at the Emerging Growth Conference on January 10, 2024
-
Daily Harvest Launches 'January Jumpstart' Program to Help People Achieve New Year's Health & Wellness Goals
-
Aegle Therapeutics Corp. Announces Positive Data for the First Patient in a Phase 1/2a Clinical Trial Dosed With AGLE-102™, a Novel Extracellular Vesicle Therapy
-
NEW CHEEZ-IT® EXTRA CRUNCHY IS HERE TO SATISFY FANS' OBSESSION WITH AN ABSURDLY AMPED UP SNACKING EXPERIENCE
-
Top 50 Master Plans Sell Over 34,000 New Homes in 2023 despite Affordability Challenges
-
Sumsub Named Leader in Multiple G2 Winter Reports
-
First-of-its-kind System Intends to Deliver Charging Ecosystem Players a Centralized Hub for Ongoing Compatibility Testing for the EV Industry
-
ChromaCode and Tennessee Oncology Sign Early Access Agreement to Collaborate on Improving Availability of Non-Small Cell Lung Cancer Biomarker Testing
-
The World's First Clinical Base Edting Therapy for Hemoglobinopathy
-
SUPPLY CHAIN SOURCES WILL REPRESENT THREE POPULAR WELLNESS BRANDS AT CES 2024
-
TPM, S&P Global's Premier Shipping and Supply Chain Conference, to Focus on Extreme Normalization Fallout
-
Baker Hill Achieves New Milestones in 2023 & Remains Positioned for Continued Growth in Year Ahead
-
SEAGULL SCIENTIFIC APPOINTS NIGEL LEGRESLEY CHIEF EXECUTIVE OFFICER AND HAROLD BOE AS CHAIRMAN
-
Mercy Announces New Leaders to Enhance Services in Neurosciences, Surgery and GI, Women and Children
-
Novel Technology Transforms Baldness Treatment Using Beard and Body Hair
-
Guidant Financial Co-founder Addresses Talent Scarcity for Franchisors Through DOXA® Talent
-
VENTANA DESIGN TO EXHIBIT WITH HDMI AT CES 2024
-
Qvin™ Introduces Q-Pad™: Transforming Women's Health with FDA-Cleared Lab Testing using Menstrual Blood
-
JBI-802 initial Phase I data suggests therapeutic potential in sensitizing immunotherapy resistant tumors and in Myeloproliferative Neoplasms with thrombocytosis
-
Premier Research and BioCentriq Enter a Strategic Partnership to Accelerate Pre-IND Timelines and Clinical Translation of Innovative Cell Therapies
-
Collaborative Classroom and FluentSeeds Merge to Expand Impact from Birth Through Grade 8
-
KeifeRx Expands Exclusive Licensing Agreement with Georgetown University to Include Multiple Disease Indications for Portfolio of Novel Tyrosine Kinase Inhibitors
-
PAN GLOBAL INTERSECTS 1.6% COPPER OVER 9.7 METERS CONFIRMING CONTINUITY OF LA ROMANA COPPER-TIN-SILVER DISCOVERY OVER 1.4KM
-
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
-
Trinity Capital Inc. Originates $831 Million in New Commitments in 2023
-
Callan Adds Sarie Diloné to Alternatives Consulting Team
-
Biohaven Highlights Progress Across Innovative Portfolio and Outlines 2024 Anticipated Milestones at the 42nd Annual J.P. Morgan Healthcare Conference; Established Extensive Portfolio Across 20 Therap
-
DeFi Technologies Subsidiary Valour Inc. Provides Monthly Corporate Update: Set Record High C$530.9 Million in Assets Under Management
-
AGNICO EAGLE PROVIDES NOTICE OF RELEASE OF FOURTH QUARTER AND FULL YEAR 2023 RESULTS AND CONFERENCE CALL
-
New Report from Tripod Education Reveals Big Changes to K-12 Coming in 2024
